Federated Hermes
RUBY

Federated Hermes’s Rubius Therapeutics, Inc RUBY Stock Holding History

Federated Hermes’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-989,100
Closed -$5.45M – 2336
2022
Q1 		$5.45M Hold
989,100
– – 0.01% 757
2021
Q4 		$9.57M Hold
989,100
– – 0.02% 659
2021
Q3 		$17.7M Sell
989,100
-159,155
-14% -$3.46M 0.03% 502
2021
Q2 		$28M Sell
1,148,255
-173,100
-13% -$4.33M 0.05% 404
2021
Q1 		$35M Buy
1,321,355
+721,355
+120% +$10.5M 0.07% 360
2020
Q4 		$4.55M Sell
600,000
-3,625
-0.6% -$21.5K 0.01% 827
2020
Q3 		$3.02M Sell
603,625
-100
-0% -$530 0.01% 861
2020
Q2 		$3.61M Buy
603,725
+3,725
+0.6% +$22K 0.01% 802
2020
Q1 		$2.67M Buy
600,000
+275,000
+85% +$2.04M 0.01% 805
2019
Q4 		$3.09M Hold
325,000
– – 0.01% 912
2019
Q3 		$2.55M Hold
325,000
– – 0.01% 973
2019
Q2 		$5.11M Buy
325,000
+78,070
+32% +$1.26M 0.01% 777
2019
Q1 		$4.47M Hold
246,930
– – 0.01% 813
2018
Q4 		$3.97M Sell
246,930
-103,070
-29% -$1.88M 0.01% 804
2018
Q3 		$8.4M Buy
+350,000
New +$8M 0.02% 632

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Federated Hermes's RUBY Position: Q2 2022 in Review

Federated Hermes sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 989,100 shares — an estimated $5.45M sold.

Federated Hermes first reported a position in RUBY in Q3 2018 and held it in 15 quarters. The position peaked at $35M in Q1 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • Federated Hermes reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • Federated Hermes sold 989,100 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $5.45M.
  • Federated Hermes first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 15 quarters.
  • Federated Hermes's Rubius Therapeutics, Inc position peaked at $35M in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Federated Hermes's 13F filing for Q2 2022, filed 15 Aug 2022.